Alethia Biotherapeutics to present at the Annual AACR Meeting at Walter E. Washington Convention Center, Washington, D.C., USA. Dr. Mario Filion and Dr. Julie Laurin will present: “Phase 1 first-in-human study of anti-clusterin antibody AB-16B5 in patients with advanced solid malignancies”.
Poster presentation CT098, April 4 2017, 8:00 AM – 12:00 PM, section 33, Session PO.CT03 – Phase I Clinical Trials